Third-Party Reimbursement Issues During a Phase 1 Trial of Interleukin-2
- 5 April 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 81 (7) , 544-545
- https://doi.org/10.1093/jnci/81.7.544
Abstract
NICHOLAS J. VOGELZANG, JON M. RICHARDS; Third-Party Reimbursement Issues During a Phase 1 Trial of Interleukin-2, JNCI: Journal of the National Cancer InstitutKeywords
This publication has 0 references indexed in Scilit: